CYTYC CORP 4
4 · CYTYC CORP · Filed Dec 16, 2004
Insider Transaction Report
Form 4
CYTYC CORPCYTC
LINDER JAMES
Sr. VP, Chief Medical Officer
Transactions
- Sale
Common Stock
2004-12-15$28.21/sh−4,500$126,938→ 2,663 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-12-15−4,500→ 38,000 totalExercise: $0.83From: 1999-12-14Exp: 2005-12-14→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2004-12-15$0.83/sh+4,500$3,750→ 7,163 total
Footnotes (4)
- [F1]Granted pursuant to Issuer's 1989 Stock Plan and exempt from Section 16 pursuant to Rule 16b-3.
- [F2]The sale reported on this Form 4 was made pursuant to a written trading plan adopted in accordance with SEC Rule 10b5-1 on March 4, 2004.
- [F3]These options, originally a grant of 600,000 shares, of which 460,000 have been exercised, vested 2.08% per month commencing on 12/14/95 for a period of four years until exercisable in full.
- [F4]Price not applicable to this transaction.